Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vasogen Inc.

Division of Intellipharmaceutics International Inc.

Latest From Vasogen Inc.

IntelliPharmaCeutics and Vasogen to merge

IntelliPharmaCeutics (IPC) and Vasogen, two Canadian pharmaceutical companies, are to merge, providing IPC with a listing on Nasdaq and the Toronto Stock Exchange (TSX).

Cardiovascular Neurology

Vasogen halts all development work

Vasogen has halted development of all its drug candidates as it continues to explore "strategic alternatives".

Cardiovascular Companies

Deals Update (06/2007)

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Inflammation
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Intellipharmaceutics International Inc.
  • Senior Management
  • Christopher J Waddick, Pres. & CEO
  • Contact Info
  • Vasogen Inc.
    Phone: (905) 817-2000
    2505 Meadowvale Blvd.
    Mississauga , L5N 5S2